Kenneth A. Clark - 03 Jan 2023 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Director
Signature
/s/ Kenneth A. Clark
Issuer symbol
SMMT
Transactions as of
03 Jan 2023
Net transactions value
+$74,148
Form type
4
Filing time
05 Jan 2023, 15:12:43 UTC
Previous filing
05 Jan 2022
Next filing
04 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +35,000 35,000 03 Jan 2023 Common Stock 35,000 $5.00 Direct F1, F2
transaction SMMT Stock Option (right to buy) Award $74,148 +44,400 +127% $1.67 79,400 03 Jan 2023 Common Stock 44,400 $5.00 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on January 3, 2023. The shares underlying the option shall vest in four equal annual installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-employee director on each such vesting date.
F2 Not applicable.
F3 The option was issued on January 3, 2023. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-employee director on each such vesting date.
F4 The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $74,000.